4,198
Views
55
CrossRef citations to date
0
Altmetric
Review Article

Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis

, , , ORCID Icon, , , ORCID Icon, , , , , , , ORCID Icon, & show all
Pages 1-14 | Received 14 May 2018, Accepted 06 Aug 2018, Published online: 27 Sep 2018

References

  • TorgersonPRMastroiacovoPThe global burden of congenital toxoplasmosis: a systematic reviewBull. World Health Organ.201391 501 50810.2471/BLT.12.111732
  • AfonsoEEnvironmental determinants of spatial and temporal variations in the transmission of Toxoplasma gondii in its definitive hostsInt. J. Parasitol. Parasites Wildl.2013227828510.1016/j.ijppaw.2013.09.006
  • BowieWROutbreak of toxoplasmosis associated with municipal drinking waterLancet199735017317710.1016/S0140-6736(96)11105-3
  • DemarMFatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspectsClin. Infect. Dis.200745e88e9510.1086/521246
  • SilveiraCOcular involvement following an epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, BrazilAm. J. Ophthalmol.201515910131021.e310.1016/j.ajo.2015.02.017
  • BoyerKUnrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North AmericaClin. Infect. Dis.2011531081108910.1093/cid/cir667
  • WHO. Multicriteria-based ranking for risk management of food-borne parasites. http://www.who.int/foodsafety/publications/mra_23/en/. Accessed 5 Dec 2016.
  • McLeodRManagement of congenital toxoplasmosisCurr. Pediatr. Rep.2014216619410.1007/s40124-014-0055-7
  • WallonMCongenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 yearsClin. Infect. Dis.2013561223123110.1093/cid/cit032
  • Cortina-BorjaMPrenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort studyPLoS Med.20107e100035110.1371/journal.pmed.1000351
  • StillwaggonECarrierCSSautterMMcLeodRMaternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic modelPLoS Negl. Trop. Dis.20115e133310.1371/journal.pntd.0001333
  • PrusaARCongenital toxoplasmosis in Austria: prenatal screening for prevention is cost-savingPLoS Negl. Trop. Dis.201711e000564810.1371/journal.pntd.0005648
  • PomaresCMontoyaJGLaboratory diagnosis of congenital toxoplasmosisJ. Clin. Microbiol.2016542448245410.1128/JCM.00487-16
  • McPhillie, M. et al. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci. Rep. 6 (2016).
  • El Bissati, K. et al. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight1, e85955 (2016).
  • WelschMEDiscovery of potent and selective leads against Toxoplasma gondii dihydrofolate reductase via structure-based designACS Med. Chem. Lett.201671124112910.1021/acsmedchemlett.6b00328
  • StecJModification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondiiChemMedChem201381138116010.1002/cmdc.201300050
  • JohnsonSMDevelopment of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activityJ. Med. Chem.2012552416242610.1021/jm201713h
  • ZhouYSpiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivoAntimicrob. Agents Chemother.2014581789179210.1128/AAC.02225-13
  • El BissatiKEffectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic miceVaccine2014323243324810.1016/j.vaccine.2014.03.092
  • Gómez-MarínJEGCongenital toxoplasmosis in South American childrenSci. Med.201020103107
  • NetoECAmorimFLagoEGEstimation of the regional distribution of congenital toxoplasmosis in Brazil from the results of neonatal screeningSci. Med.2010206470
  • Gómez-MarinJEFirst Colombian multicentric newborn screening for congenital toxoplasmosisPLoS Negl. Trop. Dis.20115e119510.1371/journal.pntd.0001195
  • Villena, I. et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill.15,19600 (2010).
  • NOGAREDAF.LE STRATY.VILLENAI.DE VALKH.GOULETV.Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimationEpidemiology and Infection2013142081661167010.1017/S0950268813002756
  • RobertsTFrenkelJKEstimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United StatesJ. Am. Vet. Med. Assoc.1990196249256
  • LiuQToxoplasma gondii infection in pregnant women in ChinaTrans. R. Soc. Trop. Med. Hyg.200910316216610.1016/j.trstmh.2008.07.008
  • GaoXJToxoplasma gondii infection in pregnant women in ChinaParasitology201213913914710.1017/S0031182011001880
  • ShinDWChaDYHuaQJChaGHLeeYHSeroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, KoreaKorean J. Parasitol.20094712513010.3347/kjp.2009.47.2.125
  • HanKShinDWLeeTYLeeYHSeroprevalence of Toxoplasma gondii infection and risk factors associated with seropositivity of pregnant women in KoreaJ. Parasitol.20089496396510.1645/GE-1435.1
  • SakikawaMAnti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in JapanClin. Vaccine Immunol.20121936536710.1128/CVI.05486-11
  • YamadaHProspective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methodsJ. Clin. Microbiol.2011492552255610.1128/JCM.02092-10
  • MoriokaIAwareness of and knowledge about mother-to-child infections in Japanese pregnant womenCongenit. Anom. (Kyoto)201454354010.1111/cga.12030
  • NissapatornVToxoplasmosis: prevalence and risk factorsJ. Obstet. Gynaecol.20032361862410.1080/01443610310001604376
  • TerazawaAMuljonoRSusantoLMargonoSSKonishiEHigh Toxoplasma antibody prevalence among inhabitants in Jakarta, IndonesiaJpn. J. Infect. Dis.200356107109
  • SinghSPanditAJIncidence and prevalence of Toxoplasmosis in Indian pregnant women: a prospective studyAm. J. Reprod. Immunol.20045227628310.1111/j.1600-0897.2004.00222.x
  • MinbaevaGToxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosisPLoS Negl. Trop. Dis.20137e204310.1371/journal.pntd.0002043
  • WalpoleIRHodgenNBowerCCongenital toxoplasmosis: a large survey in western AustraliaMed. J. Aust.1991154720724
  • KarunajeewaHSiebertDHammondRGarlandSKellyHSeroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for managementAust. N. Z. J. Obstet. Gynaecol.200141232810.1111/j.1479-828X.2001.tb01289.x
  • BergerFGouletVLe StratYDesenclosJCToxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003Rev. Épidémiol. Sante Publique20095724124810.1016/j.respe.2009.03.006
  • JonesJLKruszon-MoranDRiveraHNPriceCWilkinsPPToxoplasma gondii seroprevalence in the United States 2009–2010 and comparison with the past two decadesAm. J. Trop. Med. Hyg.2014901135113910.4269/ajtmh.14-0013
  • PeyronFCongenital Toxoplasmosis in France and the United States: one parasite, two diverging approachesPLoS Negl. Trop. Dis.201711e000522210.1371/journal.pntd.0005222
  • DubeyJPToxoplasma gondii oocyst survival under defined temperaturesJ. Parasitol.19988486286510.2307/3284606
  • FrenkelJKRuizAChinchillaMSoil survival of toxoplasma oocysts in Kansas and Costa Rica*Am. J. Trop. Med. Hyg.19752443944310.4269/ajtmh.1975.24.439
  • McLeodRPrematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981–2009)Clin. Infect. Dis.2012541595160510.1093/cid/cis258
  • World Development Indicators, The World Bank, (2017), https://datacatalog.worldbank.org/dataset/gdp-ranking.
  • El MansouriB[Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco]Bull. Soc. Pathol. Exot.2007100289290
  • LaboudiM[Risk factors of a positive serological test for toxoplasmosis in a pregnant women in Morocco]Parasite200916717210.1051/parasite/2009161071
  • Errifaiy, H. & Moutaj, R. Thèse No. X. Evaluation of Knowledge, Behavior and immunological status of pregnant women about Toxoplasmosis: Epidemiological study from Essaouira-Safi region, Faculty of Medicine and Pharmacy, (Cadi Ayyad University, Morocco), (2014).
  • Akourim, M. Perception et séroprévalence de la Toxoplasmose chez les femmes enceintes: Enquête épidémiologique dans la région Agadir– Inzegane. Universite Cadi Ayyad, Faculte de Medecine et de Pharmacie, Marrakech (2016).
  • MessererLBouzbidSGourbdjiEMansouriRBachiFSéroprévalence de la toxoplasmose chez les femmes enceintes dans la wilaya d’Annaba, AlgérieRev. Épidémiol. Sante Publique20146216016510.1016/j.respe.2013.11.072
  • FakhfakhNKallelKEnnigroSFacteur de risque pour toxoplasma gondii et status immunitaire des femmes parturientes; relation de cause à effetTunis. Med.201391188190
  • BarilLRisk factors for Toxoplasma infection in pregnancy: a case-control study in FranceScand. J. Infect. Dis.19993130530910.1080/00365549950163626
  • JonesJLToxoplasmosis-related knowledge and practices among pregnant women in the United StatesInfect. Dis. Obstet. Gynecol.20031113914510.1080/10647440300025512
  • Cañón-FrancoWALópez-OrozcoNGómez-MarínJEDubeyJPAn overview of seventy years of research (1944 – 2014) on toxoplasmosis in Colombia, South AmericaParasit. Vectors2014742710.1186/1756-3305-7-427
  • BehnkeMSVirulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinasesProc. Natl Acad. Sci. USA20111089631963610.1073/pnas.1015338108
  • de-la-TorreASevere South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levelsPLoS Negl. Trop. Dis.20137e254110.1371/journal.pntd.0002541
  • KaranisPAldeyarbiHMMirhashemiMEKhalilKMThe impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and updateEnviron. Sci. Pollut. Res. Int.201320869910.1007/s11356-012-1177-5
  • Gomez-MarinJToxoplasma gondii, BrazilEmerg. Infect. Dis.20071351251310.3201/eid1303.060599
  • Cortes JA, et al.. Clinical practice guideline. integral care guidelines for the prevention, early detection and treatment of pregnancy, childbirth and puerperium complications: Section on toxoplasmosis in pregnancy. Infectio [Internet]. 21, 102–16 (2017).
  • Chicaíza, L. et al. Cost Effectiveness of Diagnostic Strategies for Opportune Detection of Toxoplasma gondii in Pregnant Women. (Social Science Research Network, 2012).
  • LykinsJUnderstanding Toxoplasmosis in the United States through ‘large data’ analysesClin. Infect. Dis.20166346847510.1093/cid/ciw356
  • JonesJLKruszon-MoranDWilsonMToxoplasma gondii infection in the United States, 1999–2000Emerg. Infect. Dis.200391371137410.3201/eid0911.030098
  • Contopoulos-IoannidisDClustering of Toxoplasma gondii infections within families of congenitally infected infantsClin. Infect. Dis.2015611815182410.1093/cid/civ721
  • McLeodROutcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis StudyClin. Infect. Dis.2006421383139410.1086/501360
  • NobleAGChorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis StudySci. Med.201020202610.15448/1980-6108.2010.1.5930
  • OlariuTRRemingtonJSMcLeodRAlamAMontoyaJGSevere congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infantsPediatr. Infect. Dis. J.2011301056106110.1097/INF.0b013e3182343096
  • GuerinaNGNeonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working GroupN. Engl. J. Med.19943301858186310.1056/NEJM199406303302604
  • MaldonadoYvonne A.ReadJennifer S.Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United StatesPediatrics20171392e2016386010.1542/peds.2016-3860
  • BegemanIJPoint-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countriesPLoS Negl. Trop. Dis.201711e000567010.1371/journal.pntd.0005670
  • ThulliezPScreening programme for congenital toxoplasmosis in FranceScand. J. Infect. Dis. Suppl.1992844345
  • NogaredaFLe StratYVillenaIDe ValkHGouletVIncidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimationEpidemiol. Infect.20141421661167010.1017/S0950268813002756
  • KiefferFWallonMCongenital toxoplasmosisHandb. Clin. Neurol.20131121099110110.1016/B978-0-444-52910-7.00028-3
  • PeyronFSerotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America)Microbes Infect.200682333234010.1016/j.micinf.2006.03.023
  • Brenier-PinchartMPBertiniRLMaubonDPellouxHIn vitro differential phenotypic characteristics among type-II Toxoplasma gondii strains from congenital toxoplasmosis in humansJ. Parasitol.20109679879910.1645/GE-2405.1
  • WallonMPeyronFEffect of antenatal treatment on the severity of congenital toxoplasmosisClin. Infect. Dis.20166281181210.1093/cid/civ1035
  • FrenkelJKSmithDDImmunization of cats against shedding of toxoplasma oocystsJ. Parasitol.19826874474810.2307/3280978
  • FrenkelJKPfefferkornERSmithDDFishbackJLProspective vaccine prepared from a new mutant of Toxoplasma gondii for use in catsAm. J. Vet. Res.199152759763
  • Mateus-PinillaNEDubeyJPChoromanskiLWeigelRMA field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swineJ. Parasitol.19998585586010.2307/3285821
  • BuxtonDThomsonKMaleySWrightSBosHJVaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnantVet. Rec.1991129899310.1136/vr.129.5.89
  • BuxtonDInnesEAA commercial vaccine for ovine toxoplasmosisParasitology1995110S11S1610.1017/S003118200000144X
  • ChapeyEWallonMPeyronFEvaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgMClin. Chim. Acta201746420020110.1016/j.cca.2016.10.023
  • MahincCarolineFloriPierreDelaunayEdouardGuillermeCécileCharaouiSanaRaberinHélèneHafidJamalL'OllivierCoralieEvaluation of a New Immunochromatography Technology Test (LDBio Diagnostics) To Detect Toxoplasma IgG and IgM: Comparison with the Routine Architect TechniqueJournal of Clinical Microbiology201755123395340410.1128/JCM.01106-17
  • FlegrJaroslavPrandotaJosephSovičkováMichaelaIsrailiZafar H.Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 CountriesPLoS ONE201493e9020310.1371/journal.pone.0090203
  • BatzMHoffmannSMorrisJGDisease-outcome trees, EQ-5D scores, and estimated annual losses of quality-adjusted life years (QALYs) for 14 foodborne pathogens in the United StatesFoodborne Pathog. Dis.20141139540210.1089/fpd.2013.1658
  • NgôHMToxoplasma modulates signature pathways of human epilepsy, neurodegeneration & cancerSci. Rep.2017710.1038/s41598-017-10675-6
  • Di Mario, S. et al. in Cochrane Database of Systematic Reviews London, United Kingdom, (John Wiley & Sons, Ltd., 2015).